$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | Next Super Stock conference presenters: CYDY, MDCL, HOTH, NEXCF delivering results, and positioned for transformational growth in coming months
Copyright 2019 – OTC M […]
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab
Copyright 2019 – OTC Markets Group Inc.
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | Wall Street Reporter presents: “Next Super Stock – Live!” August 15, 2019
Copyright 2019 – OTC Markets Group Inc.
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial
Copyright 2019 – OTC Markets Group Inc.
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Files a Phase 2 Protocol with the FDA for Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer
Copyright 2019 – OTC M […]
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | Patient Treated with Leronlimab (PRO 140) for Metastatic Triple-Negative Breast Cancer under Emergency IND, Launching CytoDyn into Oncology
Copyright 2019 – OTC Markets Group Inc.
$CYDY#OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn Granted Small Business Waiver of Application Fees by FDA for Leronlimab (PRO 140) BLA Filing
Copyright 2019 – OTC Markets Group Inc.
